3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents
Description
Development of novel agents that prevent thrombotic events is an urgent task considering increasing incidence of cardiovascular diseases and coagulopathies that accompany cancer and COVID-19. Enzymatic assay identified novel GSK3β inhibitors in a